Facebook
Twitter
Telegram
Fehler meldenNurix Therapeutics Bilanz 2011-2024 | NRIX
Bilanz Jährlich Nurix Therapeutics
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-24 M | -52.5 M | -67.5 M | -119 M | -34.8 M | -25.6 M | - | - | - | - | - | - | - |
Langfristige Schulden |
23.1 M | 6.43 M | 9.19 M | - | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
7.49 M | 5.53 M | 3.85 M | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 61.5 M | 85.6 M | 49.4 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
87 M | 70.7 M | 66.3 M | 44.5 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
155 M | 113 M | 134 M | 106 M | 102 M | 82.2 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
48.1 M | 37.6 M | 41.2 M | 32.8 M | 9.61 M | 28.4 M | - | - | - | - | - | - | - |
Gewinnrücklagen |
-545 M | -401 M | -221 M | -104 M | -60.5 M | -38.8 M | - | - | - | - | - | - | - |
Vermögenswerte |
356 M | 417 M | 477 M | 396 M | 44 M | 45.4 M | - | - | - | - | - | - | - |
Zahlungsmittel |
54.6 M | 64.5 M | 80.5 M | 119 M | 35 M | - | - | - | - | - | - | - | - |
Buchwert |
200 M | 304 M | 342 M | 290 M | -57.7 M | -36.8 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
200 M | 304 M | 342 M | 290 M | -57.7 M | -36.8 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Nurix Therapeutics
| 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
21.8 M | 23.1 M | 2.64 M | 3.76 M | 5.11 M | 6.43 M | 7.74 M | 9.04 M | 10.3 M | 9.19 M | - | - | 9.19 M | 10.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
144 M | 155 M | 74.4 M | 90.7 M | 96.1 M | 113 M | 117 M | 128 M | 132 M | 134 M | 118 M | 120 M | 134 M | 106 M | 106 M | 106 M | 106 M | 53.6 M | 53.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
46.1 M | 48.1 M | 32 M | 44.1 M | 38.3 M | 37.6 M | 36.3 M | 41.3 M | 43.2 M | 41.2 M | 35.2 M | 33.8 M | 41.2 M | 32.8 M | 32.8 M | 32.8 M | 32.8 M | 9.61 M | 9.61 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-587 M | -545 M | -503 M | -466 M | -442 M | -401 M | -355 M | -309 M | -263 M | -221 M | -183 M | -154 M | -221 M | -104 M | -104 M | -104 M | -104 M | -60.5 M | -60.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
313 M | 356 M | 308 M | 351 M | 370 M | 417 M | 459 M | 394 M | 438 M | 477 M | 493 M | 518 M | 477 M | 396 M | 396 M | 396 M | 396 M | 44 M | 44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
49.8 M | 54.6 M | 42.3 M | 59 M | 33.6 M | 64.5 M | 47.6 M | 41.5 M | 78.8 M | 80.5 M | 147 M | 188 M | 80.5 M | 119 M | 119 M | 119 M | 119 M | 34.8 M | 34.8 M | - | - | 25.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
169 M | 200 M | 234 M | 260 M | 274 M | 304 M | 343 M | 267 M | 306 M | 342 M | 375 M | 398 M | 342 M | 290 M | 290 M | 290 M | 290 M | -9.52 M | -9.52 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
169 M | 200 M | 234 M | 260 M | 274 M | 304 M | 343 M | 267 M | 306 M | 342 M | 375 M | 398 M | 270 M | 290 M | 290 M | 290 M | 290 M | -57.7 M | -57.7 M | -42.2 M | -39.4 M | -36.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung